Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Shooting date : 2018-04-06 Last update : 2018-09-19
Language(s) : English
This didactic procedure concerns a 81 y.o gentelman, with history of Surgical Aortic valve bioprosthesis replacement with Mitroflow 21; presenting heart failure due to severe aortic prosthesis dysfunction (severe Aortic regurgitation); after Heart Team discussion, he was considered for Valve-in-Valve TAVI With Auto-expandable Evolut-R valve.
Optimal Echo-guided Femoral access for TAVI Procedures.
Managing degenerative aortic bioprosthesis with Valve -in-Valve implantation in High risk patients.
Optimal choice and sizing of the Valve-in-Valve device.
Dealing with Valve positioning and deployment in case of severe Aortic regurgitation.
Protection of coronary arteries from occlusion in High risk patients during TAVI procedures.
Echo-guided Right Femoral artery access, Left femoral access & right radial artery access.
Right Femoral artery access 14F, Left femoral artery access 7F, Right radial artery access 5F.
Protection of the Right coronary artery with 7F JR4 guiding catheter & workhorse coronary guidewire (Sion blue) (Over left femoral access).
Placing a 5Fr Pigtail catheter in the ascending aorta through Right Radial access.
Preclosing the right Femoral access with two Proglide devices (Abbott).
First evaluation aortography.
Crossing the degenerated valve with AL1 5F Catheter and regular wire.
Loading the 14 F introducer.
Pre-implantation Pressure parameters recording.
Exchange the regular guidewire with Safari guidewire.
Evolut-R Valve loading, Fluoroscopic chek of the valve.
Evolut-R valve optimal positioning, recapture and second positioning for best compromise between coronary occlusion risk and transvalvular residual gradient.
Partial release of the Evolut-R valve and angiographic control.
Pulling back the Pigtail 5F Catheter & the JR4 7F protection guiding catheter.
Final release of the valve.
Post-implantation pressure parmeters recording.
Angiographic control of the Coronary arteries patency.
Monday, November 30th -0001 from 12am to 12am (GMT+1)
Honolulu : Monday, November 29th 1999 from 01pm to 01pm (GMT-10) San Francisco : Monday, November 29th 1999 from 03pm to 03pm (GMT-8) New York : Monday, November 29th 1999 from 06pm to 06pm (GMT-5) Buenos Aires : Monday, November 29th 1999 from 08pm to 08pm (GMT-3) London / Dublin : Monday, November 29th 1999 from 11pm to 11pm (GMT) Paris / Berlin : Tuesday, November 30th 1999 from 12am to 12am (GMT+1) Istanbul : Tuesday, November 30th 1999 from 01am to 01am (GMT+2) Moscou / Dubaï : Tuesday, November 30th 1999 from 03am to 03am (GMT+4) Bangkok : Tuesday, November 30th 1999 from 06am to 06am (GMT+7) Shanghai : Tuesday, November 30th 1999 from 07am to 07am (GMT+8) Tokyo : Tuesday, November 30th 1999 from 08am to 08am (GMT+9) Sydney : Tuesday, November 30th 1999 from 09am to 09am (GMT+10) Wellington : Tuesday, November 30th 1999 from 11am to 11am (GMT+12)